User profiles for Sean P Moran
Sean P MoranBroad Institute of MIT and Harvard Verified email at broadinstitute.org Cited by 936 |
[HTML][HTML] Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Support for the N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis of
schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an …
schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an …
lncRNA DIGIT and BRD3 protein form phase-separated condensates to regulate endoderm differentiation
Cooperation between DNA, RNA and protein regulates gene expression and controls
differentiation through interactions that connect regions of nucleic acids and protein domains and …
differentiation through interactions that connect regions of nucleic acids and protein domains and …
Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders
Muscarinic acetylcholine receptors (mAChR) play important roles in regulating complex
behaviors such as cognition, movement, and reward, making them ideally situated as potential …
behaviors such as cognition, movement, and reward, making them ideally situated as potential …
M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition
SP Moran, JW Dickerson, HP Cho, Z Xiang… - …, 2018 - nature.com
Highly selective positive allosteric modulators (PAMs) of the M 1 subtype of muscarinic
acetylcholine receptor have emerged as an exciting new approach for improving cognitive …
acetylcholine receptor have emerged as an exciting new approach for improving cognitive …
[PDF][PDF] Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice
A genetically valid animal model could transform our understanding of schizophrenia (SCZ)
disease mechanisms. Rare heterozygous loss-of-function (LoF) mutations in GRIN2A, …
disease mechanisms. Rare heterozygous loss-of-function (LoF) mutations in GRIN2A, …
A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity
…, HP Cho, PM Garcia-Barrantes, SP Moran… - ACS chemical …, 2018 - ACS Publications
Selective activation of the M 1 subtype of muscarinic acetylcholine receptor, via positive
allosteric modulation (PAM), is an exciting strategy to improve cognition in schizophrenia and …
allosteric modulation (PAM), is an exciting strategy to improve cognition in schizophrenia and …
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256
MD Grannan, CA Mielnik, SP Moran… - ACS chemical …, 2016 - ACS Publications
Abnormalities in the signaling of the N-methyl-d-aspartate subtype of the glutamate receptor
(NMDAR) within cortical and limbic brain regions are thought to underlie many of the …
(NMDAR) within cortical and limbic brain regions are thought to underlie many of the …
Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells
Chronic liver injury causes fibrosis, characterized by the formation of scar tissue resulting
from excessive accumulation of extracellular matrix (ECM) proteins. Hepatic stellate cell (HSC) …
from excessive accumulation of extracellular matrix (ECM) proteins. Hepatic stellate cell (HSC) …
M1 muscarinic receptors modulate fear-related inputs to the prefrontal cortex: implications for novel treatments of posttraumatic stress disorder
Background The prefrontal cortex (PFC) integrates information from multiple inputs to exert
top-down control allowing for appropriate responses in a given context. In psychiatric …
top-down control allowing for appropriate responses in a given context. In psychiatric …
Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys
…, S Bosinger, Z Johnson, G Tharp, SP Moran… - Brain, behavior, and …, 2016 - Elsevier
Although the most notable clinical symptoms of Huntington’s disease (HD) are motor
disturbances and brain atrophy, other symptoms include cognitive dysfunction, emotional and …
disturbances and brain atrophy, other symptoms include cognitive dysfunction, emotional and …